Clinical studies of pazufloxacin in obstetrics and gynecology
スポンサーリンク
概要
- 論文の詳細を見る
We investigated the clinical effects of pazufloxacin (PZFX), a newly developed oral quinolone agent, in the gynecological infectious diseases.<BR>PZFX was orally administered to 11 patients with Bartholin's abscess, pyosalpinx, salpingitis and cervicitis.<BR>Among these cases, 8 were evaluated as effective, 3 as unknown.(The efficacy rate was 100%.)<BR>Of the 3 cases, 1 case with cervicitis was excluded because of infection with Trichomonas. The 2 cases of salpingitis were excluded because of under unclar symptoms of infection.<BR>PZFX was effective for gynecological infectious disease.<BR>Bacteriologically 6 species, 10 strains were isolated from 7 patients.(The eradication rate was 90%.)<BR>No side effects were observed during the treatment.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.